{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:29:04Z","timestamp":1787509744252,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["KACST 2-17-03-001-0014"],"award-info":[{"award-number":["KACST 2-17-03-001-0014"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.pedneo.2022.10.006","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T03:06:24Z","timestamp":1671159984000},"page":"327-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of vancomycin individualized model-based dosing approach in neonates"],"prefix":"10.1016","volume":"64","author":[{"given":"Manal","family":"Abouelkheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Almohaizeie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Almuhisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7013-8369","authenticated-orcid":false,"given":"Abdullah","family":"Alsultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2022.10.006_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2471\/BLT.14.139790","article-title":"Neonatal cause-of-death estimates for the early and late neonatal periods for 194 countries: 2000-2013","volume":"93","author":"Oza","year":"2015","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.pedneo.2022.10.006_bib2","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.pedneo.2022.10.006_bib3","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0378-3782(12)70019-1","article-title":"Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units","volume":"88","author":"Hornik","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.pedneo.2022.10.006_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12887-016-0753-0","article-title":"Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?","volume":"16","author":"Padari","year":"2016","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.pedneo.2022.10.006_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12098-008-0056-z","article-title":"Sepsis in the newborn","volume":"75","author":"Sankar","year":"2008","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.pedneo.2022.10.006_bib6","first-page":"476","article-title":"Challenges of vancomycin dosing and therapeutic monitoring in neonates","volume":"25","author":"Pham","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.pedneo.2022.10.006_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12098-019-03153-6","article-title":"How to treat sepsis in the background of resistance?: role of pharmacodynamics\/pharmacokinetics in treating sepsis","volume":"87","author":"Agrawal","year":"2020","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.pedneo.2022.10.006_bib8","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1128\/AAC.03620-14","article-title":"Association between vancomycin trough concentration and area under the concentration-time curve in neonates","volume":"58","author":"Frymoyer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2022.10.006_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jiac.2016.11.009","article-title":"Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates","volume":"23","author":"Kato","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.pedneo.2022.10.006_bib10","doi-asserted-by":"crossref","first-page":"624639","DOI":"10.3389\/fped.2021.624639","article-title":"Model-Informed precision dosing of antibiotics in pediatric patients: a narrative review","volume":"9","author":"Abdulla","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pedneo.2022.10.006_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jpids\/pix109","article-title":"Individualized empiric vancomycin dosing in neonates using a model-based approach","volume":"8","author":"Frymoyer","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.pedneo.2022.10.006_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cts.12490","article-title":"Precision dosing: public Health need, proposed framework, and anticipated impact","volume":"10","author":"Gonzalez","year":"2017","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.pedneo.2022.10.006_bib13","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jsps.2020.08.012","article-title":"Clinical pharmacology applications in clinical drug development and clinical care: a focus on Saudi Arabia","volume":"28","author":"Alsultan","year":"2020","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.pedneo.2022.10.006_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/cpt.659","article-title":"Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future","volume":"101","author":"Darwich","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pedneo.2022.10.006_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cpt.593","article-title":"Scalpels not hammers: the way forward for precision drug prescription","volume":"101","author":"Neely","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pedneo.2022.10.006_bib16","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pedneo.2022.10.006_bib17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pedneo.2022.10.006_bib18","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/INF.0000000000001943","article-title":"Optimizing vancomycin monitoring in pediatric patients","volume":"37","author":"Alsultan","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pedneo.2022.10.006_bib19","series-title":"Targeting vancomycin AUC in neonates \u2212 A model-based bayesian approach for personalized therapeutic drug monitoring","author":"Stockmann","year":"2015"},{"key":"10.1016\/j.pedneo.2022.10.006_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/jpids\/piu110","article-title":"Pharmacodynamic characteristics of nephrotoxicity associated with vancomycin use in children","volume":"4","author":"Le","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.pedneo.2022.10.006_bib21","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/AAC.02214-15","article-title":"Clinical utility and safety of a model-based patient-tailored dose of vancomycin in neonates","volume":"60","author":"Leroux","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2022.10.006_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/archdischild-2012-302765","article-title":"Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring","volume":"98","author":"Zhao","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pedneo.2022.10.006_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02523-20","article-title":"Population pharmacokinetic analysis and dose regimen optimization in Japanese infants with an extremely low birth weight","volume":"65","author":"Sasano","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2022.10.006_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","article-title":"Human renal function maturation: a quantitative description using weight and postmenstrual age","volume":"24","author":"Rhodin","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pedneo.2022.10.006_bib25","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s10096-018-3277-8","article-title":"Factors impacting unbound vancomycin concentrations in neonates and young infants","volume":"37","author":"Smits","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.pedneo.2022.10.006_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","article-title":"The clinical relevance of plasma protein binding changes","volume":"52","author":"Roberts","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pedneo.2022.10.006_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2146\/ajhp130308","article-title":"Outcomes of a new dosage regimen of amikacin based on pharmacokinetic parameters of Korean neonates","volume":"71","author":"An","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pedneo.2022.10.006_bib28","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/AAC.01157-15","article-title":"Prospective evaluation of a model-based dosing regimen for amikacin in preterm and term neonates in clinical practice","volume":"59","author":"Smits","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2022.10.006_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fphar.2019.00641","article-title":"Optimizing vancomycin dosing in chronic kidney disease by deriving and implementing a web-based tool using a population pharmacokinetics analysis","volume":"10","author":"Dorajoo","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pedneo.2022.10.006_bib30","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/bcp.14360","article-title":"Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients","volume":"86","author":"Ter Heine","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2022.10.006_bib31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2146\/ajhp160260","article-title":"Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations","volume":"74","author":"Brown","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pedneo.2022.10.006_bib32","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/AAC.03970-14","article-title":"Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis","volume":"59","author":"Casapao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2022.10.006_bib33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/cid\/ciu398","article-title":"Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?","volume":"59","author":"Lodise","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pedneo.2022.10.006_bib34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/bmj.39104.625903.80","article-title":"Information technology cannot guarantee patient safety","volume":"334","author":"de Wildt","year":"2007","journal-title":"BMJ"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957222002583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957222002583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:12:34Z","timestamp":1778829154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957222002583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1875957222002583"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2022.10.006","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of vancomycin individualized model-based dosing approach in neonates","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2022.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}